Cipla Q2 Results
- BSE: 500087
- NSE: CIPLA
- ISIN: INE059A01026
- Sector: Biotechnology & Drugs
BSE
1,298.80
-15.30 (-1.16%)
-15.30 (-1.16%)Volume19.32 K
Updated: Mon 16 Mar, 2026 | 15:46:40
NSE
1,300-14.70 (-1.12%)
-14.70 (-1.12%)Volume1.50 M
Updated: Mon 16 Mar, 2026 | 15:40:48
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Cipla Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 5,991.68 | 5,432.05 | 10.30% | 5,437.17 | 10.20% |
| Depreciation/ Amortization | 296.99 | 252.72 | 17.52% | 271.74 | 9.29% |
| Operating Income | 1,597.76 | 1,525.42 | 4.74% | 1,613.85 | -1.00% |
| Net Income | 1,351.17 | 1,297.62 | 4.13% | 1,302.53 | 3.73% |
| Other Operating Expenses Total | 1,882.25 | 1,696.32 | 10.96% | 1,674.54 | 12.40% |
| Net Income Before Taxes | 1,853.53 | 1,769.93 | 4.72% | 1,789.06 | 3.60% |
| Total Revenue | 7,589.44 | 6,957.47 | 9.08% | 7,051.02 | 7.64% |
| Selling/ General/ Admin Expenses Total | 1,314.80 | 1,312.30 | 0.19% | 1,207.88 | 8.85% |
| Diluted Normalized EPS | 16.72 | 16.06 | 4.11% | 16.12 | 3.72% |